PSEUDOMONAS PRODUCTS, OXYGEN RADICALS, AND LUNG INJURY
PSEUDOMONAS PRODUCTS, OXYGEN RADICALS, AND LUNG INJURY
批准号:
6624631
负责人:
BRADLEY E BRITIGAN
金额:
$24.57万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-12-01 至 2004-11-30
关键词:
Pseudomonas aeruginosa bacterial cytopathogenic effect bacterial pigment bacterial toxins cell transplantation cellular pathology cystic fibrosis cytotoxicity free radical oxygen interleukin 8 lung injury microorganism culture oxidative stress protein purification respiratory epithelium tissue /cell culture
中文摘要
铜绿假单胞菌引起急性医院获得性肺炎以及
囊性纤维化患者的慢性肺部感染。的机制
导致肺损伤的原因尚不清楚。形成
氧化剂物质如超氧化物和过氧化氢
多种形式的肺损伤。在最初的融资期间,
程序,我们获得的证据表明,三个化合物积极分泌的P。
铜绿假单胞菌通过氧化损伤肺上皮和内皮细胞
生产在下一个融资期,我们将定义蜂窝
氧化还原循环的作用机制。这导致超氧化物和
产生过氧化氢。绿脓菌素会导致大量有害的
对体外和体内细胞功能的影响。尽管如此,
关于细胞的细胞事件只有有限的数据。此外,委员会认为,
产生氧化剂的部位、机制和性质
绿脓菌素以及细胞靶点也知之甚少。我们
假设绿脓菌素介导的一系列复杂效应发生
通过其诱导位点特异性氧化剂产生的能力,
破坏细胞能量产生和氧化剂活化
敏感的信号通路。为了验证这一假设,
将被完成。目的1是确定上皮细胞的机制,
细胞获取、细胞运输和绿脓菌素的代谢
在体外条件下。目的2是确定绿脓菌素如何消耗
上皮细胞的ATP和cAMP,通过定义绿脓菌素对
氧化磷酸化和糖酵解。这一目标还将解决,如果
绿脓菌素作用于氧化剂调节的信号通路,IL-8表达
将作为一个模型系统。前两个目标将使用体外
使用正常和CF细胞的极化上皮细胞单层系统。
目的3将研究绿脓菌素在体外的影响程度
在体内条件下观察到。这项工作将集中在IL-8
释放和利用人呼吸道上皮细胞的异种移植物,
SCID小鼠。这些研究将使用最先进的细胞技术,
生物学和氧化剂化学来定义新的和以前未探索的
铜绿假单胞菌可能导致急性和/或慢性
肺损伤
英文摘要
Pseudomonas aeruginosa causes acute nosocomial pneumonia as well as
chronic lung infections in cystic fibrosis patients. The mechanisms
responsible for the resulting lung injury remain unclear. Formation of
oxidant species such as superoxide and hydrogen peroxide are associated
with many forms of lung injury. During the initial funding period of this
program, we obtained evidence that three compounds actively secreted by P.
aeruginosa damage pulmonary epithelial and endothelial cells via oxidant
production. In the next funding period we will define the cellular
mechanisms of action of redox cycling. This results in superoxide and
hydrogen peroxide generation. Pyocyanin causes a host of deleterious
effects on cellular functions both in vitro and in vivo. In spite of this,
there is only limited data on the cellular events by cells. Furthermore,
the site(s), mechanism(s), and nature of the oxidants produced by
pyocyanin, as well as the cellular targets are also poorly understood. We
hypothesize that the complex series of effects mediated by pyocyanin occur
through its ability to induce site specific oxidant production which leads
to the disruption of cellular energy generation and activation of oxidant
sensitive signaling pathways. To test this hypothesis three specific aims
will be accomplished. Aim 1 is to identify the mechanism(s) of epithelial
cell acquisition, cellular trafficking, and metabolism of pyocyanin under
in vitro conditions. Aim 2 is to determine how pyocyanin deplete
epithelial cells of ATP and cAMP by defining the effects of pyocyanin on
oxidative phosphorylation and glycolysis. This aim will also address if
pyocyanin acts on oxidant-regulated signaling pathways, IL-8 expression
will serve as a model system. The first two aims will use an in vitro
system of polarized epithelial cell monolayers using normal and CF cells.
Aim 3 will examine the extent to which the in vitro effects of pyocyanin
are observed occur under in vivo conditions. This work will focus on IL-8
release and utilize xenografts of human respiratory epithelial cells in
SCID mice. These studies will use state of the art technique of cell
biology and oxidant chemistry to define novel and previously unexplored
mechanisms whereby P. aeruginosa may contribute to acute and/or chronic
lung injury.
期刊论文(32)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Doxorubicin inhibits oxidation of 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonate) (ABTS) by a lactoperoxidase/H(2)O(2) system by reacting with ABTS-derived radical.
Doxorubicin 通过与 ABTS 衍生的自由基反应,抑制乳过氧化物酶/H(2)O(2) 系统对 2,2-azino-bis(3-乙基苯并噻唑啉-6-磺酸盐) (ABTS) 的氧化。
DOI:
10.1016/j.abb.2007.06.027
发表时间:
2007
期刊:
Archives of biochemistry and biophysics
影响因子:
3.9
作者:
[Reszka,KrzysztofJ, Britigan,BradleyE]
通讯作者:
Britigan,BradleyE
Photosensitized oxidation and inactivation of pyocyanin, a virulence factor of Pseudomonas aeruginosa.
绿脓杆菌(铜绿假单胞菌的毒力因子)的光敏氧化和失活。
DOI:
10.1562/2005-07-29-ra-626
发表时间:
2006
期刊:
Photochemistry and photobiology.
影响因子:
--
作者:
[Reszka,KrzysztofJ, Denning,GereneM, Britigan,BradleyE]
通讯作者:
Britigan,BradleyE
DOI:
10.1042/0264-6021:3500797
发表时间:
2000-09
期刊:
The Biochemical journal
影响因子:
--
作者:
[M. McCormick;G. Denning;K. Reszka;P. Bilski;G. Buettner;G. T. Rasmussen;M. A. Railsback;B. Britigan]
通讯作者:
M. McCormick;G. Denning;K. Reszka;P. Bilski;G. Buettner;G. T. Rasmussen;M. A. Railsback;B. Britigan
Oxidation of thiols and modification of redox-sensitive signaling in human lung epithelial cells exposed to Pseudomonas pyocyanin.
暴露于绿脓杆菌的人肺上皮细胞中硫醇的氧化和氧化还原敏感信号的修饰。
DOI:
10.1080/15287394.2010.514233
发表时间:
2011
期刊:
Journal of toxicology and environmental health. Part A
影响因子:
--
作者:
[Ahmad,ImanM, Britigan,BradleyE, Abdalla,MaherY]
通讯作者:
Abdalla,MaherY
Inactivation of anthracyclines by serum heme proteins.
血清血红素蛋白使蒽环类药物失活。
DOI:
10.1021/tx700002f
发表时间:
2007
期刊:
Chemical research in toxicology
影响因子:
4.1
作者:
[Wagner,BrettA, Teesch,LynnM, Buettner,GarryR, Britigan,BradleyE, Burns,CPatrick, Reszka,KrzysztofJ]
通讯作者:
Reszka,KrzysztofJ
共 16 条
Development of Gallium-Based Therapies for Pulmonary Mycobacterial Infections
-
批准号:9275424
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
Iron Acquisition by Mycobacterium tuberculosis Within Phagocytes
-
批准号:7685175
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
Iron Acquisition by Mycobacterium tuberculosis Within Phagocytes
-
批准号:8601148
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
Iron Acquisition by Mycobacterium tuberculosis Within Phagocytes
-
批准号:8195964
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
Iron Acquisition by Mycobacterium tuberculosis Within Phagocytes
-
批准号:7784541
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
Use of Gallium to Prevent Pseudomonas Biofilm Formation
-
批准号:6944895
-
项目类别:
-
资助金额:$19.68万
-
财政年份:2004
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
Use of Gallium to Prevent Pseudomonas Biofilm Formation
-
批准号:6807809
-
项目类别:
-
资助金额:$17.18万
-
财政年份:2004
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
PSEUDOMONAS PRODUCTS, OXYGEN RADICALS, AND LUNG INJURY
-
批准号:6124279
-
项目类别:
-
资助金额:$22.49万
-
财政年份:1993
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
PSEUDOMONAS PRODUCTS, OXYGEN RADICALS, AND LUNG INJURY
-
批准号:2607819
-
项目类别:
-
资助金额:$19.75万
-
财政年份:1993
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
PSEUDOMONAS PRODUCTS, OXYGEN RADICALS, AND LUNG INJURY
-
批准号:2070249
-
项目类别:
-
资助金额:$17.11万
-
财政年份:1993
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
PSEUDOMONAS PRODUCTS, OXYGEN RADICALS, AND LUNG INJURY
-
批准号:2004014
-
项目类别:
-
资助金额:$18.41万
-
财政年份:1993
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
PSEUDOMONAS PRODUCTS, OXYGEN RADICALS, AND LUNG INJURY
-
批准号:2070250
-
项目类别:
-
资助金额:$17.17万
-
财政年份:1993
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
PSEUDOMONAS PRODUCTS, OXYGEN RADICALS, AND LUNG INJURY
-
批准号:2758868
-
项目类别:
-
资助金额:$23.86万
-
财政年份:1993
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
PSEUDOMONAS PRODUCTS, OXYGEN RADICALS, AND LUNG INJURY
-
批准号:6475692
-
项目类别:
-
资助金额:$23.86万
-
财政年份:1993
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
PSEUDOMONAS PRODUCTS, OXYGEN RADICALS, AND LUNG INJURY
-
批准号:2070251
-
项目类别:
-
资助金额:$17.78万
-
财政年份:1993
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
PSEUDOMONAS PRODUCTS, OXYGEN RADICALS, AND LUNG INJURY
-
批准号:6328724
-
项目类别:
-
资助金额:$23.16万
-
财政年份:1993
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
MONOCYTE/MACROPHAGE FREE RADICAL BIOLOGY ASSESSED BY EPR
-
批准号:2221414
-
项目类别:
-
资助金额:$9.3万
-
财政年份:1989
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
MONOCYTE/MACROPHAGE FREE RADICAL BIOLOGY ASSESSED BY EPR
-
批准号:3473001
-
项目类别:
-
资助金额:$9.86万
-
财政年份:1989
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
MONOCYTE/MACROPHAGE FREE RADICAL BIOLOGY ASSESSED BY EPR
-
批准号:3472998
-
项目类别:
-
资助金额:$6.7万
-
财政年份:1989
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
MONOCYTE/MACROPHAGE FREE RADICAL BIOLOGY ASSESSED BY EPR
-
批准号:3472999
-
项目类别:
-
资助金额:$7.63万
-
财政年份:1989
-
负责人:BRADLEY E BRITIGAN
-
依托单位: